This research suggests that both c-Cbl and Cbl-b–mediated ubiquitination hold the key for DC subset homeostasis and immune quiescence under steady‐state conditions, implying that c-Cbl and Cbl-b may have the potential to be therapeutic targets for the treatment of DC-mediated liver inflammation (42). Here, CBLB is linked to Hepatitis.